SYH2056
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 19, 2026
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Effect of Food of SYH2056 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=72 | Not yet recruiting | Sponsor: InnovStone Therapeutics Limited
New P1 trial
1 to 1
Of
1
Go to page
1